Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned

{
  "signal_id": "9ffcb1bd-3746-ff9d-351d-ebde685da622",
  "signal_type": "news",
  "signal_subtype": "decreases_headcount_by",
  "detected_at": "2026-09-02T13:12:35+00:00",
  "company": {
    "name": "Novartis",
    "domain": "novartis.com"
  },
  "data": {
    "url": "https://www.bazonline.ch/novartis-130-stellen-in-basel-fallen-bis-2027-weg-141623316611",
    "title": "Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned - Basler Zeitung",
    "excerpt": "Novartis is discontinuing small-volume biologics production and relocating it to other sites worldwide. Expiring lease agreements are the reason for the decision.\nThe pharmaceutical company Novartis is cutting up to 130 jobs in Basel by the end of 2027. The reason is that small-volume biologics production in Kleinbasel will be abandoned, the company announced on Wednesday. In the future, other biologics sites worldwide are to take over the tasks of the Basel factory, it further states.\nThe background to the discontinuation of production is that individual lease agreements at the Kleinbasel site were expiring. Therefore, further activities would be relocated from Kleinbasel to the Novartis Campus on the other side of the Rhine, according to the communiqué. These include laboratories for biological cell banks, analytical testing procedures, and technical development activities.\nThe relocation represents the next step in the already announced plans to establish a new center for the technical development of biologics on the campus, the communiqué further states. This is intended to complement the existing research center for biologics.\nAccording to the information, all planned changes are subject to the information and consultation process. Novartis is committed to supporting affected employees with a range of offers – including a long-running social plan.",
    "summary": "Novartis is cutting up to 130 jobs in Basel by the end of 2027 due to the closure of its small-volume biologics production in Kleinbasel.",
    "location": "Basel, Switzerland",
    "planning": true,
    "headcount": 130,
    "image_url": "https://cdn.unitycms.io/images/0LMy8e0-qWEBXeY_s138za.jpg?op=ocroped&val=1200,600,1000,750,125,0&sum=wKfWKSu0_Do",
    "confidence": 0.9,
    "published_at": "2026-09-02T13:12:35Z",
    "location_data": [
      {
        "city": "Basel",
        "state": "Basel-Stadt",
        "region": "Western Europe",
        "country": "Switzerland",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2027-12-31",
    "article_sentence": "The pharmaceutical company Novartis is cutting up to 130 jobs in Basel by the end of 2027."
  }
}

curl https://signals.autobound.ai/v1/signals/9ffcb1bd-3746-ff9d-351d-ebde685da622 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","limit":20}'